CBD-rich cannabis extract dramatically increased a "probiotic" gut bacterium in mice but also triggered intestinal inflammation
In mice, a CBD-rich cannabis extract dramatically increased Akkermansia muciniphila (a bacterium considered probiotic) while simultaneously triggering pro-inflammatory responses and decreasing gut integrity markers.
Quick Facts
What This Study Found
CBD-rich cannabis extract (CRCE) at multiple doses substantially increased the gut bacterium Akkermansia muciniphila (currently considered probiotic) in mouse fecal samples. However, this was accompanied by increased pro-inflammatory cytokines and chemokines (IL-1β, CXCL1, CXCL2) in colon tissue, and the increased A. muciniphila significantly decreased expression of Muc2, a gene critical for gut integrity.
Key Numbers
All CRCE doses increased A. muciniphila; IL-1β, CXCL1, CXCL2 increased in colon; Muc2 expression decreased; effects at doses from 61.5 to 615 mg/kg/day.
How They Did This
Male C57BL/6J mice gavaged with CRCE (0, 61.5, 184.5, or 615 mg/kg/day) for 2 weeks. Gut microbiome analyzed by 16S sequencing; colonic gene expression measured by qPCR; histomorphological analysis of gut mucosa.
Why This Research Matters
CBD products are marketed for gut health, but this study shows a paradox: CBD increased a "beneficial" bacterium while simultaneously triggering inflammation. This challenges simplistic narratives about CBD gut effects and raises safety concerns about long-term use.
The Bigger Picture
The gut is emerging as a key site of cannabinoid action. This study demonstrates that "good" microbiome changes (more A. muciniphila) can coexist with harmful tissue effects (inflammation, reduced mucus integrity). Microbiome composition alone does not predict gut health.
What This Study Doesn't Tell Us
Mouse model (gut microbiome differs from humans); CBD-rich extract (not pure CBD; contains other cannabinoids); high doses relative to human use; 2-week duration; male mice only; inflammatory markers do not necessarily indicate clinical disease.
Questions This Raises
- ?Would pure CBD have the same paradoxical gut effects?
- ?Are these inflammatory changes clinically relevant at human-equivalent doses?
Trust & Context
- Key Stat:
- CBD increased "probiotic" A. muciniphila but also triggered gut inflammation
- Evidence Grade:
- Preliminary: novel and concerning finding, but mouse model with high doses and CBD-rich extract rather than pure CBD.
- Study Age:
- Published 2020.
- Original Title:
- Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract.
- Published In:
- Journal of dietary supplements, 17(5), 543-560 (2020)
- Authors:
- Skinner, Charles M(2), Nookaew, Intawat, Ewing, Laura E(2), Wongsurawat, Thidathip, Jenjaroenpun, Piroon, Quick, Charles M, Yee, Eric U, Piccolo, Brian D, ElSohly, Mahmoud, Walker, Larry A, Gurley, Bill, Koturbash, Igor
- Database ID:
- RTHC-02848
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Is CBD good for gut health?
It may be more complicated than assumed. This study found CBD-rich extract increased a bacterium considered beneficial while simultaneously triggering intestinal inflammation and reducing gut integrity. This paradox warrants caution about long-term CBD use for gut health.
What was the concerning finding?
While A. muciniphila (considered probiotic) dramatically increased, pro-inflammatory markers (IL-1β, CXCL1, CXCL2) also increased in the colon, and the gene for gut-protective mucus (Muc2) decreased. Good bacteria and bad inflammation can coexist.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02848APA
Skinner, Charles M; Nookaew, Intawat; Ewing, Laura E; Wongsurawat, Thidathip; Jenjaroenpun, Piroon; Quick, Charles M; Yee, Eric U; Piccolo, Brian D; ElSohly, Mahmoud; Walker, Larry A; Gurley, Bill; Koturbash, Igor. (2020). Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract.. Journal of dietary supplements, 17(5), 543-560. https://doi.org/10.1080/19390211.2020.1761506
MLA
Skinner, Charles M, et al. "Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract.." Journal of dietary supplements, 2020. https://doi.org/10.1080/19390211.2020.1761506
RethinkTHC
RethinkTHC Research Database. "Potential Probiotic or Trigger of Gut Inflammation - The Jan..." RTHC-02848. Retrieved from https://rethinkthc.com/research/skinner-2020-potential-probiotic-or-trigger
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.